NUS Links:
N2CR had the honour of having Dr Sophia Adamia, from the Beth Israel Deaconess Medical Center in Boston, visit us on 5 Sept to give a talk titled ‘RNA “backpack”
On 4th and 5th September 2023, N2CR had the honour of holding the NUS-Kanagawa Symposium 2023, jointly with CSI Singapore and institutes from Kanagawa Prefecture, Japan. These institutes include the
Several N2CR Members have been featured in the top 20 biology and biochemistry scientists in Singapore for their outstanding work in the biological and medical fields. Check out the list
After 2 years, N2CR had its very first Staff Retreat! Held at the Republic of Singapore Yacht Club, our primary, secondary, affiliate and associate members came together to talk about
A/Prof Takaomi Sanda, Dr Lim Fang Qi and team have shown how PIK-75, a drug dismissed over 10 years ago, is proving vital in treating aggressive blood cancer, especially in
CanCycle 2023 is now in full swing! Thank you for all your support thus far 🙂 Read on to find more about the people you’d be making a difference to.
N2CR member, A/Prof Too Heng-Phon, Dr Sarah Ho and team have developed a way to use stem cells to treat cancer in cats and dogs, a method originally developed for
Precision Cancer Medicine thematic member, Dr Yong Wei Peng was part of a team who developed an antibody-drug conjugate (ADC), the first of its kind to be created in Singapore.
A/Prof Koh Liang Piu, member of the N2CR Tissue-Specific Carcinogenesis theme, helped to develop a cell selection technique that gives blood cancer patients a higher chance of finding a match
(image credit: The Straits Times) For the past two decades, Prof Too has played a tremendous role in strengthening life sciences research and development in Singapore. His steadfast dedication